PDCD1LG2 and breast cancer: We here report that chronic inhibition of ERα signaling triggers an immunosuppressive transcriptional program in ER+ BC cells, which includes the activation of multiple immune checkpoints such as PD‐L1 and PD‐L2, together with a reduced expression of the antigen‐presenting machinery.